Markus Hörer

745 total citations
15 papers, 581 citations indexed

About

Markus Hörer is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Markus Hörer has authored 15 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Markus Hörer's work include Virus-based gene therapy research (14 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and CAR-T cell therapy research (4 papers). Markus Hörer is often cited by papers focused on Virus-based gene therapy research (14 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and CAR-T cell therapy research (4 papers). Markus Hörer collaborates with scholars based in Germany, United States and Switzerland. Markus Hörer's co-authors include Jürgen A. Kleinschmidt, Caroline Geisen, Felix Hoppe‐Seyler, J A Kleinschmidt, Karin Butz, Stefan Weger, Margit Weghofer, Karen Nieto, Axel Mescheder and Daniel Y. Sze and has published in prestigious journals such as PLoS ONE, Journal of Virology and Biotechnology and Bioengineering.

In The Last Decade

Markus Hörer

14 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Hörer Germany	9	447	316	167	149	94	15	581
Marko Marttila Sweden	7	506 1.1×	336 1.1×	206 1.2×	143 1.0×	192 2.0×	8	624
Rebecca A. Nace United States	16	487 1.1×	229 0.7×	250 1.5×	164 1.1×	129 1.4×	30	634
Frances J. Morling United Kingdom	12	592 1.3×	542 1.7×	122 0.7×	104 0.7×	58 0.6×	12	734
Taco G. Uil Netherlands	17	628 1.4×	606 1.9×	334 2.0×	57 0.4×	147 1.6×	21	839
Laurent Deleu Germany	11	391 0.9×	265 0.8×	169 1.0×	67 0.4×	188 2.0×	13	543
Lisa A. Santry Canada	14	157 0.4×	191 0.6×	140 0.8×	90 0.6×	69 0.7×	23	472
Yukiharu Sawada Japan	12	375 0.8×	342 1.1×	228 1.4×	75 0.5×	82 0.9×	20	560
Christian Grossardt Germany	9	531 1.2×	203 0.6×	360 2.2×	146 1.0×	108 1.1×	10	645
Fouzia Amirache France	14	369 0.8×	379 1.2×	228 1.4×	254 1.7×	96 1.0×	15	726
Marilyn Fernandez United States	9	308 0.7×	181 0.6×	139 0.8×	168 1.1×	114 1.2×	17	569

Countries citing papers authored by Markus Hörer

Since Specialization

Citations

This map shows the geographic impact of Markus Hörer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hörer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hörer more than expected).

Fields of papers citing papers by Markus Hörer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hörer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hörer. The network helps show where Markus Hörer may publish in the future.

Co-authorship network of co-authors of Markus Hörer

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Hörer. A scholar is included among the top collaborators of Markus Hörer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Hörer. Markus Hörer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Breunig, Karin D., et al.. (2025). Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution. Molecular Therapy — Methods & Clinical Development. 33(1). 101417–101417.

Fisher, Krishna J., Rupert Derler, Florian Sonntag, et al.. (2025). Polo-like kinase inhibitors increase AAV production by halting cell cycle progression. Molecular Therapy — Methods & Clinical Development. 33(1). 101412–101412. 1 indexed citations

Fisher, Krishna J., et al.. (2024). Transcriptomics-informed pharmacology identifies epigenetic and cell cycle regulators that enhance AAV production. Molecular Therapy — Methods & Clinical Development. 32(4). 101384–101384. 2 indexed citations

Reid, Christopher A., Markus Hörer, & Mohammad A. Mandegar. (2024). Advancing AAV production with high-throughput screening and transcriptomics. Cell and Gene Therapy Insights. 10(6). 821–840. 5 indexed citations

Schmidt, Erika, et al.. (2019). Evaluation of life cycle defective adenovirus mutants for production of adeno‐associated virus vectors. The Journal of Gene Medicine. 21(6). e3094–e3094. 5 indexed citations

Singer, Josef, Krisztina Manzano-Szalai, Judit Fazekas, et al.. (2016). Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platform. OncoImmunology. 5(7). e1171446–e1171446. 17 indexed citations

Fischer, Simon, Karlheinz Holzmann, René Handrick, et al.. (2015). Temperature‐sensitive miR‐483 is a conserved regulator of recombinant protein and viral vector production in mammalian cells. Biotechnology and Bioengineering. 113(4). 830–841. 25 indexed citations

Holzmann, Karlheinz, et al.. (2013). Novel approaches to render stable producer cell lines viable for the commercial manufacturing of rAAV-based gene therapy vectors. BMC Proceedings. 7(S6). 3 indexed citations

Nieto, Karen, Margit Weghofer, Peter Sehr, et al.. (2012). Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate. PLoS ONE. 7(6). e39741–e39741. 68 indexed citations

10.

Sonntag, Florian, Katja Schmidt, Margit Weghofer, et al.. (2011). The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes. Journal of Virology. 85(23). 12686–12697. 133 indexed citations

11.

Geevarghese, Sunil K., David A. Geller, Markus Hörer, et al.. (2010). Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver. Human Gene Therapy. 21(9). 1119–1128. 122 indexed citations

12.

Bogedain, C., Markus Hörer, Markus Braun‐Falco, et al.. (1998). Recombinant Adeno-Associated Virus for the Generation of Autologous, Gene-Modified Tumor Vaccines: Evidence for a High Transduction Efficiency into Primary Epithelial Cancer Cells. Human Gene Therapy. 9(7). 1049–1059. 26 indexed citations

13.

Hallek, Michael, Anne Girod, Markus Braun‐Falco, et al.. (1998). Recombinant adeno-associated virus vectors.. PubMed. 1(5). 561–73. 8 indexed citations

14.

Hörer, Markus, Stefan Weger, Karin Butz, et al.. (1995). Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. Journal of Virology. 69(9). 5485–5496. 122 indexed citations

15.

Hörer, Markus, et al.. (1994). Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants. Journal of Virology. 68(11). 7169–7177. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact